MRI characteristics of sporadic CJD with valine homozygosity at codon 129 of the prion protein gene and PrPSc type 2 in Japan

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 3, 2004, Pages 485-487

  Fukushima, R ^a   Shiga, Y ^b,d   Nakamura, M ^a   Fujimori, J ^b   Kitamoto, T ^b,d   Yoshida, Y ^c  

^a Hiraka General Hospital   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

^d Japanese CJD Surveillance Committee ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE; PRION PROTEIN; PROTEIN SUBUNIT; VALINE;

AGED; AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; CODON; CREUTZFELDT JAKOB DISEASE; DIFFUSION WEIGHTED IMAGING; DISEASE CLASSIFICATION; EUROPE; FEMALE; GENETIC ANALYSIS; HOMOZYGOSITY; HUMAN; HYPOTHALAMUS NUCLEUS; JAPAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION GENETICS; PRIORITY JOURNAL; PULVINAR; SEQUENCE ANALYSIS; THALAMUS; THALAMUS DORSOMEDIAL NUCLEUS; THALAMUS VENTRAL NUCLEUS; UNITED STATES;

AGED; AUTOPSY; CODON; CREUTZFELDT-JAKOB SYNDROME; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; JAPAN; MALE; PRIONS; PRPSC PROTEINS; THALAMUS; VALINE;

EID: 1542407288     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2002.008011     Document Type: Article

References (17)

1. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-5.
2. Will RG, Zeidler M, Stewart GE, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000;47:575-82.
3. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-33.
4. Doh-ura K, Kitamoto T, Sakaki Y, et al. CJD discrepancy. Nature 1991;353:801-2.
5. Miyazono M, Kitamoto T, Doh-ura K, et al. Creutzfeldt-Jakob disease with codon 129 polymorphism (Valine): a comparative study of patients with codon 102 point mutation or without mutations. Acta Neuropathol 1992;84:349-54.
6. Brownell B, Oppenheimer DR. An ataxic form of subacute presenile polioencephalopathy (Creutzfeldt-Jakob disease). J Neurol Neurosurg Psychiatry 1965;28:350-61.
7. Damaerel P, Heiner L, Robberecht W, et al. Diffusion-weighted MRI in sporadic Creutzfeldt-Jakob disease. Neurology 1999;52:205-8.
8. Mittal S, Farmer P, Kalina P, et al. Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt-Jakob disease. Arch Neurol 2002;59:128-34.
9. Zeidler M, Sellar RJ, Collie DA. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 2000;355:1412-18.
10. Kretzschmar HA, Ironside JW, DeArmond SJ, et al. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neural 1996;53:913-20.
11. Schröter A, Zerr I, Henkel K, et al. Magnetic resonance imaging in the Creutzfeldt-Jakob disease. Arch Neurol 2000;57:1751-7.
12. Finkenstaedt M, Szudra A, Zerr I, et al. MR imaging of Creutzfeldt-Jakob disease. Radiology 1996;199:793-8.
13. Samman I, Schulz-Schaeffer WJ, Wöhrle JC, et al. Clinical ranqe and MRI in Creutzfeldt-Jakob disease with heterozygosity at codon 129 and prion protein type2. J Neurol Neurosurg Psychiatry 1999;67:678-81.
14. Bahn MM, Parchi P. Abnormal diffusion-weighted magnetic resonance imaging in Creutzfeldt-Jakob disease. Arch Neurol 1999;56:577-83.
15. Collie DA, Sellar RJ, Zeidler M, et al. MRI of Creutzfeldt-Jakob disease: Imaging features and recommended MRI protocol. Clin Radiology 2001;54:726-39.
16. Report of a WHO consultation. Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies. WHO/EMC/ZDI/98.9. World Health Organization: Geneva, 1998.
17. Shiga Y, Asano M, Sato S, et al. Diagnostic importance of diffusion-weighted magnetic resonance imaging for Creutzfeldt-Jakob disease (abstract). Ann Neurol 2002;52(Suppl 1):S53.